NCT05826925 Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
| NCT ID | NCT05826925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Hypertension, Pregnancy Induced |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-07-15 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-07-15 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.
Eligibility Criteria
Inclusion Criteria: * Delivered a pregnancy complicated by a hypertensive disorder of pregnancy at the University of Utah during the current hospital admission * Ability to speak and read English or Spanish * Written informed consent obtained Exclusion Criteria: * Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction) * Impairment of cognitive function or vision that prohibits communication and/or reading the decision aid.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05826925 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Hypertension, Pregnancy Induced. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05826925 currently recruiting?
Yes, NCT05826925 is actively recruiting participants. Contact the research team at lauren.theilen@hsc.utah.edu for enrollment information.
Where is the NCT05826925 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT05826925 clinical trial?
NCT05826925 is sponsored by University of Utah. The trial plans to enroll 30 participants.